v3.21.1
Statements of Operations - USD ($)
12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Revenues:    
Total Revenues $ 31,243
Selling, general and administrative expenses 4,882,877 4,911,613
Research and development expenses 4,252,249 2,206,120
Loss on impairment of intangible asset 588,822
Loss from Operations (9,135,126) (7,675,312)
Other (Income) Expense:    
Interest (income) expense, net (3,739) (49,915)
Change in fair value of derivative liabilities (211,807)
Other expenses 215,906
Total Other (Income) Expense 360 (49,915)
Net Loss (9,135,486) (7,625,397)
Deemed dividend to Series C Preferred Stockholders (607,220)
Net Loss Attributable to Common Stockholders $ (9,742,706) $ (7,625,397)
Net Loss Per Basic and Diluted Common Share: $ (7.54) $ (12.10)
Weighted Average Number of Common Shares Outstanding: Basic and Diluted 1,291,469 630,418
Royalty Income [Member]    
Revenues:    
Total Revenues $ 31,243

Source